Answers are grounded in this paper and cite their sources.
Cadmium (Cd²⁺) is a non-essential heavy metal, which is taken up from the environment into the body through pulmonary and enteral pathways. The S1 segment of the kidney proximal tubule (PT) is a major target of chronic Cd²⁺ toxicity. Renal dysfunction develops in up to 7% of the general population and in its most severe form displays major features of Fanconi syndrome, such as a defective protein, amino acid, glucose, bicarbonate and phosphate reabsorption. The major pathway for Cd²⁺ uptake by PT cells (PTCs) in vivo is apical endocytosis of Cd²⁺ complexed to the high-affinity metal-binding protein metallothionein (MT), which may be receptor-mediated. MT is subsequently degraded in endo-lysosomes, and Cd²⁺ is liberated for translocation into the cytosolic compartment, possibly using transporters for Fe²⁺, Zn²⁺ or Cu²⁺, such as the divalent metal transporter DMT1. Free Cd²⁺ ions in the extracellular space are translocated across apical and/or basolateral PTC membranes into the cytosol via transporters, whose identity remains unknown. Cytosolic Cd²⁺ generates reactive oxygen species (ROS), which deplete endogenous radical scavengers. ROS also damage a variety of transport proteins, including the Na⁺/K⁺-ATPase, which are subsequently degraded by the proteasome and endo-lysosomal proteases. Cd²⁺ causes mitochondrial swelling and release of cytochrome c. If these ROS-mediated stress events are not balanced by repair processes, affected cells undergo apoptosis. But Cd²⁺ also induces the upregulation of cytoprotective stress and metal-scavenging proteins, such as MT. In addition, Cd²⁺ upregulates the detoxifying pump multidrug resistance P-glycoprotein, which appears to protect PTCs against Cd²⁺-induced apoptosis. Thus, Cd²⁺ interferes with various cellular events ranging from mechanisms of induction of programmed cell death to activation of cell survival genes. A better understanding of the cellular mechanisms involved in Cd²⁺ nephrotoxicity should provide insights into other heavy metal (e.g. Pb²⁺, Hg²⁺) nephropathies and various forms of acquired Fanconi syndrome.
No takes yet. Share an insight, caveat, or question.
Frank Thévenod (2003) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: